Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

Ameriprise Financial Caps Fiscal 2025 with Historic Performance

Felix Baarz by Felix Baarz
January 30, 2026
in Banking & Insurance, Earnings, S&P 500
0
Ameriprise Stock
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

Ameriprise Financial has concluded its 2025 fiscal year by setting new company records, propelled by substantial growth in client assets and robust operational execution. The financial services firm reported a significant year-over-year increase in its adjusted quarterly earnings per share, raising the question of whether this positive trajectory can be sustained.

  • Q4 Adjusted EPS: $10.83 (a 16% increase)
  • Assets Under Management & Administration (AUA): $1.7 trillion (record high)
  • 2025 Capital Return to Shareholders: $3.4 billion
  • Declared Quarterly Dividend: $1.60 per share

Record Assets Drive Strong Earnings

A key factor behind the company’s success was the expansion of its client asset base. The total assets under management and administration soared to an unprecedented $1.7 trillion by the end of 2025, marking an 11% rise. This growth was notably fueled within the Advice & Wealth Management segment, which attracted net inflows of $13.3 billion in the fourth quarter alone, highlighting sustained high levels of client engagement.

This asset growth translated directly to the bottom line. For the final quarter, Ameriprise posted adjusted operating earnings per diluted share of $10.83, representing a 16% advance compared to the prior-year period. On a full-year basis, this metric climbed 14% to $39.29. Concurrently, adjusted operating net revenues for Q4 increased by 10%, reaching $4.9 billion.

Should investors sell immediately? Or is it worth buying Ameriprise?

Shareholder Returns Remain a Central Priority

Ameriprise continued its disciplined approach to returning capital to its investors. During the fourth quarter, the company allocated $1.1 billion to shareholders through a combination of dividend distributions and share repurchases. For the entire 2025 fiscal year, the total capital returned reached $3.4 billion, equivalent to 88% of the full-year adjusted operating net income.

The company’s pre-tax operating margin stood at 27% for the reported quarter. Coinciding with the earnings release, the Board of Directors declared a quarterly cash dividend of $1.60 per share. This dividend will be payable on February 27, 2026, to shareholders of record as of the market close on February 9, 2026.

Ad

Ameriprise Stock: Buy or Sell?! New Ameriprise Analysis from February 8 delivers the answer:

The latest Ameriprise figures speak for themselves: Urgent action needed for Ameriprise investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Ameriprise: Buy or sell? Read more here...

Tags: Ameriprise
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Tilray Stock
Analysis

Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins

February 8, 2026
Ammo Stock
Analysis

Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test

February 8, 2026
Oak Valley Stock
Banking & Insurance

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026
Next Post
Array Technologies Stock

Array Technologies Stock Climbs to Fresh Annual Peak

XRP Stock

XRP Faces Intense Selling Pressure Amid Market-Wide Turbulence

Quantum eMotion Stock

Quantum eMotion Targets US Listing with NYSE American Ambition

Recommended

Amgen Stock

Amgen’s Market Paradox: Strong Fundamentals Clash With Stock Performance

4 months ago
Adobe Stock

Adobe Shares Plunge to New Depths Amid Institutional Sell-Off

3 months ago
Omv Stock

OMV Shares Stabilize as Romanian Power Plant Resumes Operations

2 months ago
MKL stock news

Lynch Asset Management Inc. Decreases Stake in The Cigna Group, Analysts Offer Mixed Ratings and Price Targets

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

SuRo Capital Sharpens Focus on AI Infrastructure Investments

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

Trending

Tilray Stock
Analysis

Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins

by Jackson Burston
February 8, 2026
0

Tilray Brands, Inc. continues to build on its strong January performance with two significant strategic developments. The...

Ammo Stock

Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test

February 8, 2026
Berry Petroleum Stock

California Resources Navigates Post-Merger Integration and Regulatory Landscape

February 8, 2026
KemPharm Stock

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

February 8, 2026
Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tilray’s Diversification Strategy Gains Momentum with Key Operational Wins
  • Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test
  • California Resources Navigates Post-Merger Integration and Regulatory Landscape

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com